The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Insulin Resistance and Cardiovascular Disease1
Abstract
INSULIN RESISTANCE describes an impaired biological response to insulin (1–4). In the early states of insulin resistance there is a compensatory increase in insulin concentrations. Although hyperinsulinemia may compensate for resistance to some biological actions of insulin, it may result in overexpression of actions in tissues that retain normal or minimally impaired sensitivity to insulin. Also, high concentrations of insulin can act through receptors for insulin-like growth factor I (IGF-I) (5–8). Thus, accentuation of some actions of insulin with concurrent resistance to other actions gives rise to diverse clinical manifestations and sequelae of the insulin resistance syndrome. In general, insulin resistance can be due to a prereceptor, receptor, or postreceptor abnormality (1). One signaling pathway for insulin and IGF-I is the phosphatidylinositide 3-kinase (PI3 -kinase) system. Upon binding to their receptors, there is autophosphorylation of the β-subunit, which mediates noncovalent but stable interactions between the receptor and cellular proteins (1). Several proteins are then rapidly phosphorylated on tyrosine residues by ligand-bound insulin receptors, including insulin receptor substrate-1 (IRS-1) (1). IRS docking proteins bind strongly to the enzyme PI3 -kinase (1), a heterodimer consisting of a p85 regulatory subunit and a p110 catalytic subunit, via SH-2 domain interaction with the p85 subunit (1). Insulin and IGF-I stimulation increases the amount of PI3 -kinase associated with IRS, and the binding process is associated with increased activity of the enzyme. Activation of the enzyme is crucial for transducing the actions of these peptides in cardiovascular (CV) tissue (9–14) as well as conventional insulin-sensitive tissues (1). The interruption of this pathway creates a resistance to the actions of insulin/IGF-I in stimulating vascular nitric oxide (NO) production (9, 10), CV cation transport mechanisms (11, 12–15), as well as glucose transport (1, 6) (Fig. 1) in classically sensitive tissues such as muscle and adipose tissue. PI3-kinase mediates the increases in NO, Na+ pump, K+ channel, and calcium (Ca2+) myofilament sensitivity by increasing the trafficking and translocation of NO synthase and cation pump units as well as glucose transporters (1, 9, 16) (Fig. 2). Therefore, resistance to the actions of insulin and IGF-I in these tissues occurs whenever there is reduced PI3 -kinase activation (Fig. 2). The actions of insulin and IGF-I on cation metabolism and vascular tone. The actions of insulin and IGF-I on cation metabolism and vascular tone. The interactions of insulin/IGF-I and the RAS in cardiovascular tissue (−) indicates insulin/IGF-I signaling steps that are inhibited by Ang II. The interactions of insulin/IGF-I and the RAS in cardiovascular tissue (−) indicates insulin/IGF-I signaling steps that are inhibited by Ang II. Evidence has been garnered indicating that insulin resistance and the resultant hyperinsulinemia are causally related to hypertension (Table 2). First, untreated essential hypertensive patients have higher fasting and postprandial insulin levels than normotensive subjects regardless of body mass; a direct correlation between plasma insulin concentrations and blood pressure levels exists (17, 18). Second insulin resistance and hyperinsulinemia exist in rats with genetic hypertension such as the Dahl hypertensive (19), the spontaneously hypertensive (20), and the Zucker obese hypertensive rat strain (21). Finally, the relationship between insulin and hypertension seen in essential hypertension does not occur with secondary hypertension (20, 22). Accordingly, insulin resistance and hyperinsulinemia are not consequences of hypertension, but, instead, a genetic predistribution may contribute to both disorders. This concept is supported by the finding of altered glucose metabolism in normotensive offspring of hypertensive persons (22–24). Mechanisms for the development of hypertension in insulin resistance/hyperinsulinemia include activation of the sympathetic nervous system, renal sodium retention, altered transmembrane cation transport, growth-promoting effects of vascular smooth muscle cells, and vascular hyperreactivity (1–3). Cardiovascular risk factors that cluster with microalbuminuria Cardiovascular risk factors that cluster with microalbuminuria Four large prospective studies (25–28) have shown that hyperinsulinemia is a predictor of coronary artery disease (CAD), with a few prospective reports not demonstrating such a relationship. The greatest association of hyperinsulinemia with CAD has been found in Finland in a population with a very high frequency of CAD (25). Results of a prospective investigation of 2103 men from Quebec (29) clearly showed that high fasting insulin concentrations are an independent predictor of CAD. This important study used an insulin assay without cross-reactivity with proinsulin, thus avoiding that confounding influence. Several rec
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmäki, K., Dahlöf, B., de Faire, U., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 2,014
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 2×
“Second, insulin stimulation of blood flow is blunted in these individuals (59, 60, 62).”
BackgroundReaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
Gress, T. W., Nieto, F. J., Shahar, E., Wofford, M. R., & Brancati, F. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421301 · Cited by 1,202
Le Roith, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360907 · Cited by 897
Pyörälä, K. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.131 · Cited by 768
Ducimetiere, P., Eschwege, E., Papoz, L., Richard, J. L., Claude, J. R., & Rosselin, G. (1980) · Diabetologia · doi:10.1007/bf00275270 · Cited by 747
Welborn, T. A., & Wearne, K. (1979) · Diabetes Care · doi:10.2337/diacare.2.2.154 · Cited by 735
Zeng, G., & Quon, M. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118871 · Cited by 726
Salomaa, V., Riley, W., Kark, J. D., Nardo, C., & Folsom, A. R. (1995) · Circulation · doi:10.1161/01.cir.91.5.1432 · Cited by 582
Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study
Meigs, J. B., D'Agostino, R. B., Wilson, P. W., Cupples, L. A., Nathan, D. M., & Singer, D. E. (1997) · Diabetes · doi:10.2337/diabetes.46.10.1594 · Cited by 527
Relation of Serum Uric Acid to Mortality and Ischemic Heart Disease
Freedman, D. S., Williamson, D. F., Gunter, E. W., & Byers, T. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117479 · Cited by 443
Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients
Alderman, M. H., Cohen, H., Madhavan, S., & Kivlighn, S. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.144 · Cited by 441
Folli, F., Kahn, C. R., Hansen, H., Bouchie, J. L., & Feener, E. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119752 · Cited by 424
Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*
SHEN, D.-C., SHIEH, S.-M., FUH, M. M.-T., WU, D.-A., CHEN, Y.-D. I., & REAVEN, G. M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-3-580 · Cited by 420
Lehto, S., Niskanen, L., Rönnemaa, T., & Laakso, M. (1998) · Stroke · doi:10.1161/01.str.29.3.635 · Cited by 411
Cross-talk between the insulin and angiotensin signaling systems.
Velloso, L. A., Folli, F., Sun, X. J., White, M. F., Saad, M. J., & Kahn, C. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12490 · Cited by 403
Fontbonne, A., Charles, M. A., Thibult, N., Richard, J. L., Claude, J. R., Warnet, J. M., Rosselin, G. E., & Eschw�ge, E. (1991) · Diabetologia · doi:10.1007/bf00405009 · Cited by 377
Tchernof, A., Lamarche, B., Prud'homme, D., Nadeau, A., Moorjani, S., Labrie, F., Lupien, P. J., & Després, J.-P. (1996) · Diabetes Care · doi:10.2337/diacare.19.6.629 · Cited by 323
Insulin Resistance, Body Fat Distribution, and Sex Hormones in Men
Haffner, S. M., Karhapää, P., Mykkänen, L., & Laakso, M. (1994) · Diabetes · doi:10.2337/diab.43.2.212 · Cited by 307
Ren, J., Samson, W. K., & Sowers, J. R. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1036 · Cited by 304
Self-citationPatients with Alcohol Problems
O'Connor, P. G., & Schottenfeld, R. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802263380907 · Cited by 269
Insulin Increases the Association of Akt-2 with Glut4-containing Vesicles
Calera, M. R., Martinez, C., Liu, H., Jack, A. K. E., Birnbaum, M. J., & Pilch, P. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7201 · Cited by 245
Hyperinsulinemic Microalbuminuria: A New Risk Indicator for Coronary Heart Disease
Kuusisto, J., Mykkänen, L., Pyörälä, K., & Laakso, M. (1995) · Circulation · doi:10.1161/01.cir.91.3.831 · Cited by 232
Lee, J. W., Sparrow, D., Vokonas, P., Landsberg, L., & Weiss, S. T. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117634 · Cited by 221
Chen, Y.-Q., Su, M., Walia, R. R., Hao, Q., Covington, J. W., & Vaughan, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8225 · Cited by 217
Hunter, S. J., & Garvey, W. T. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00300-3 · Cited by 200
Microalbuminuria Precedes the Development of NIDDM
Mykkänen, L., Haffner, S. M., Kuusisto, J., Pyorälä, K., & Laakso, M. (1994) · Diabetes · doi:10.2337/diab.43.4.552 · Cited by 189
Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology
Sowers, J. R. (1997) · Hypertension · doi:10.1161/01.hyp.29.3.691 · Cited by 186
Self-citationBrown, N. J., Kim, K.-S., Chen, Y.-Q., Blevins, L. S., Nadeau, J. H., Meranze, S. G., & Vaughan, D. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6305 · Cited by 182
Schneider, D. J., & Sobel, B. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.9959 · Cited by 161
Cittadini, A., Ishiguro, Y., Strömer, H., Spindler, M., Moses, A. C., Clark, R., Douglas, P. S., Ingwall, J. S., & Morgan, J. P. (1998) · Circulation Research · doi:10.1161/01.res.83.1.50 · Cited by 158
Westerbacka, J., Vehkavaara, S., Bergholm, R., Wilkinson, I. B., Cockcroft, J., & Yki‐Järvinen, H. (1999) · Diabetes · doi:10.2337/diabetes.48.4.821 · Cited by 151
Banerji, M. A., Lebowitz, J., Chaiken, R. L., Gordon, D., Kral, J. G., & Lebovitz, H. E. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.2.e425 · Cited by 142
Self-citationLaine, H. K., Yki‐Järvinen, H., Kirvelä, O., Tolvanen, T., Raitakari, M., Solin, O. H., Haaparanta‐Solin, M., Knuuti, J. M., & Nuutila, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1065 · Cited by 135
Antihypertensive Therapy and the Risk of Type 2 Diabetes Mellitus
Sowers, J. R., & Bakris, G. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421310 · Cited by 129
Self-citationSex hormones and hemostatic risk factors for coronary heart disease in men with hypertension
Phillips, G. B., Jing, T.-Y., Resnick, L. M., Barbagallo, M., Laragh, J. H., & Sealey, J. E. (1993) · Journal of Hypertension · doi:10.1097/00004872-199307000-00003 · Cited by 117 · cited 1×
“Aerobic exercise has been demonstrated to improve insulin sensitivity, improve the lipoprotein profile, and lower blood pressure, thus, correcting many of the abnormalities associated with the insulin resistance syndrome (1, 35).”
BackgroundAgewall, S., Fagerberg, B., Attvall, S., Wendelhag, I., Urbanavičius, V., & Wikstrand, J. (1995) · Stroke · doi:10.1161/01.str.26.6.956 · Cited by 117
Diabetes and Cardiovascular Disease
Sowers, J. R., & Lester, M. (2021) · Elsevier eBooks · doi:10.1016/c2018-0-01893-9 · Cited by 116
Self-citationRole of Insulin Resistance Associated With Compensatory Hyperinsulinemia in Ischemic Stroke
Shinozaki, K., Naritomi, H., Shimizu, T., Suzuki, M., Ikebuchi, M., Sawada, T., & Harano, Y. (1996) · Stroke · doi:10.1161/01.str.27.1.37 · Cited by 113
Insulin resistance in offspring of hypertensive parents.
Beatty, O. L., Harper, R., Sheridan, B., Atkinson, A. B., & Bell, P. M. (1993) · BMJ · doi:10.1136/bmj.307.6896.92 · Cited by 113
Reaven, G. M., & Chang, H. (1991) · American Journal of Hypertension · doi:10.1093/ajh/4.1.34 · Cited by 103
Insulin Resistance as an Independent Risk Factor for Carotid Wall Thickening
Suzuki, M., Shinozaki, K., Kanazawa, A., Hara, Y., Hattori, Y., Tsushima, M., & Harano, Y. (1996) · Hypertension · doi:10.1161/01.hyp.28.4.593 · Cited by 101
Insulin and blood pressure among healthy children Cardiovascular risk in young finns
Taittonen, L. M. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00345-2 · Cited by 98
Begum, N., Ragolia, L., Rienzie, J., McCarthy, M., & Duddy, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25164 · Cited by 91
Hyperinsulinemia in normotensive offspring of hypertensive parents.
Grünfeld, B., Balzaretti, M., Romo, M., Gimenez, M., & Gutman, R. A. (1994) · Hypertension · doi:10.1161/01.hyp.23.1_suppl.i12 · Cited by 90
Forsblom, C. M., Eriksson, J. G., Ekstrand, A., TEPPO, A. M., Taskinen, M., & Groop, L. (1995) · Diabetologia · doi:10.1007/bf00400643 · Cited by 90
LeRoith, D., & Bondy, C. A. (1996) · Growth factors and cytokines in health and disease · doi:10.1016/s1874-5687(96)80003-6 · Cited by 90
Insulin Resistance in Microalbuminuric Hypertension
Bianchi, S., Bigazzi, R., Galvan, A. Q., Muscelli, E., Baldari, G., Pecori, N., Ciociaro, D., Ferrannini, E., & Natali, A. (1995) · Hypertension · doi:10.1161/01.hyp.26.5.789 · Cited by 89
Clustering of Endothelial Markers of Vascular Damage in Human Salt-Sensitive Hypertension
Ferri, C., Bellini, C., Desideri, G., Giuliani, E., Siati, L. D., Cicogna, S., & Santucci, A. (1998) · Hypertension · doi:10.1161/01.hyp.32.5.862 · Cited by 81
Insulin resistance and blood pressure in Dahl rats and in one-kidney, one-clip hypertensive rats
Kotchen, T. A., Zhang, H. Y., Covelli, M. M., & Blehschmidt, N. G. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.6.e692 · Cited by 81
Insulin hypersecretion: A distinctive feature between essential and secondary hypertension
Sechi, L. A., Melis, A., & Tedde, R. (1992) · Metabolism · doi:10.1016/0026-0495(92)90019-7 · Cited by 80
Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis.
Sowers, J. R., Sowers, P. S., & Peuler, J. D. (1994) · PubMed · Cited by 79
Self-citationAtherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria
Jensen, J. S., Borch‐Johnsen, K., Jensen, G. B., & Feldt‐Rasmussen, B. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05420-n · Cited by 70
Hansen, T. F., Andersen, C., Echwald, S. M., Urhammer, S. A., Clausen, J. O., Vestergaard, H., Owens, D. R., Hansen, L., & Pedersen, O. B. (1997) · Diabetes · doi:10.2337/diab.46.3.494 · Cited by 65
Mechanisms of the Kinetic Defect in Insulin Action in Obesity and NIDDM
Nolan, J. J., Ludvik, B. H., Baloga, J., Reichart, D. R., & Olefsky, J. M. (1997) · Diabetes · doi:10.2337/diab.46.6.994 · Cited by 60
Mitchell, T. H., Nolan, B., Henry, M., Cronin, C. C., Baker, H. H., & Greely, G. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00051-x · Cited by 44
Standley, P. R., Ram, J. L., & Sowers, J. R. (1993) · Endocrinology · doi:10.1210/endo.133.4.8404611 · Cited by 35
Self-citationParticipation of PI3K and atypical PKC in Na+-K+-pump stimulation by IGF-I in VSMC
Li, D., Sweeney, G., Wang, Q., & Klip, A. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h2109 · Cited by 33
Insulin, Cation Metabolism and Insulin Resistance
Sowers, J. R., & Draznin, B. (1998) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp.1998.9.2-4.223 · Cited by 26
Self-citationMetabolic abnormalities in hypertension
Afonso, L., Edelson, G. W., & Sowers, J. R. (1997) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199705000-00004 · Cited by 20
Self-citationHypertension in Type II Diabetes: Update on Therapy.
Sowers, J. R. (1999) · PubMed · Cited by 17
Self-citationFatty Acids, Not Insulin, Modulate α1-Adrenergic Reactivity in Dorsal Hand Veins
Stepniakowski, K. T., Lü, G., Miller, G. D., & Egan, B. M. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1150 · Cited by 12
Research works printed but not linked: 1
- 1999, Hypertension in type II diabetes: update on therapy., J Clin Hypertens, 1, 41
Cited by
Subcutaneous and visceral adipose tissue: Structural and functional differences
Ibrahim, M. M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00623.x · Cited by 2,238
Calhoun, D. A., Jones, D., Textor, S., Goff, D. C., Murphy, T. P., Toto, R. D., White, A., Cushman, W. C., White, W., Sica, D., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.189141 · Cited by 2,237
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Self-citationCalhoun, D. A., Jones, D., Textor, S., Goff, D. C., Murphy, T. P., Toto, R. D., White, A., Cushman, W. C., White, W., Sica, D., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.189141 · Cited by 1,413
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Self-citation
Metadata
- Authors
- McFarlane, S. I., Banerji, M., & Sowers, J. R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-02-01
- Volume
- 86
- Issue
- 2
- Pages
- 713-718
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2051181865
- Cited by
- 501
- References
- 68
- FWCI
- 19.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.